Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma.

Patients whose recurrence occurred more than 6 months after cytoreductive surgery had an OS extension of 13 months compared to those with earlier recurrences, although this difference did not reach statistical significance ( p = 0.091).

also in 111,027 other papers